L T, F M, D V, S B, et al. Adherence and forgiveness of two modern ART regimens: lamivudine/dolutegravir and emtricitabine/tenofovir alafenamide/rilpivirine. J Acquir Immune Defic Syndr 2025 Jan 2. doi: 10.1097/QAI.0000000000003594.
PMID: 39745743